Patents Assigned to AQUILON PHARMACEUTICALS
  • Patent number: 12558313
    Abstract: The present invention relates to a golf ball-like microparticles obtained by atomization of nanosuspensions of nanoparticles or solutions for dry powder inhalers for use in the treatment and prevention of pulmonary diseases.
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: February 24, 2026
    Assignee: AQUILON PHARMACEUTICALS
    Inventors: Paul Maes, Didier Cataldo, William Bigazzi, Brigitte Evrard